APO Research
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Inactivated Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Japanese Encephalitis Inactivated Vaccine Industry Research Report 2026

29 December 2025120 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Inactivated Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Inactivated Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Inactivated Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Inactivated Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Inactivated Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Inactivated Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Japanese Encephalitis Inactivated Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Japanese Encephalitis Inactivated Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Japanese Encephalitis Inactivated Vaccine include Liaoning Chengda Biological Co., Ltd, Lanzhou Institute of Biological Products Co., Ltd, Chengdu Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co., Ltd, Valneva, Sanofi Pasteur and Biken, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Japanese Encephalitis Inactivated Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Japanese Encephalitis Inactivated Vaccine Market by Company

Liaoning Chengda Biological Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Beijing Institute of Biological Products Co., Ltd

Valneva

Sanofi Pasteur

Biken

Japanese Encephalitis Inactivated Vaccine Segment by Type

Adult

Child

Japanese Encephalitis Inactivated Vaccine Segment by Application

Hospital

Clinic

Japanese Encephalitis Inactivated Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Inactivated Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Inactivated Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Inactivated Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Japanese Encephalitis Inactivated Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Japanese Encephalitis Inactivated Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Japanese Encephalitis Inactivated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Japanese Encephalitis Inactivated Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Japanese Encephalitis Inactivated Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Japanese Encephalitis Inactivated Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Japanese Encephalitis Inactivated Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Japanese Encephalitis Inactivated Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Japanese Encephalitis Inactivated Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Japanese Encephalitis Inactivated Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Japanese Encephalitis Inactivated Vaccine, Product Type & Application Table 14. Global Japanese Encephalitis Inactivated Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Japanese Encephalitis Inactivated Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Liaoning Chengda Biological Co., Ltd Company Information Table 19. Liaoning Chengda Biological Co., Ltd Business Overview Table 20. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 22. Liaoning Chengda Biological Co., Ltd Recent Developments Table 23. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 24. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 25. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 27. Lanzhou Institute of Biological Products Co., Ltd Recent Developments Table 28. Chengdu Institute of Biological Products Co., Ltd Company Information Table 29. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 30. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 32. Chengdu Institute of Biological Products Co., Ltd Recent Developments Table 33. Beijing Institute of Biological Products Co., Ltd Company Information Table 34. Beijing Institute of Biological Products Co., Ltd Business Overview Table 35. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 37. Beijing Institute of Biological Products Co., Ltd Recent Developments Table 38. Valneva Company Information Table 39. Valneva Business Overview Table 40. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 42. Valneva Recent Developments Table 43. Sanofi Pasteur Company Information Table 44. Sanofi Pasteur Business Overview Table 45. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 47. Sanofi Pasteur Recent Developments Table 48. Biken Company Information Table 49. Biken Business Overview Table 50. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 52. Biken Recent Developments Table 53. Global Japanese Encephalitis Inactivated Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 54. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (K Units) Table 55. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2021-2026) Table 56. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2027-2032) & (K Units) Table 57. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2027-2032) Table 58. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2021-2026) Table 60. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2027-2032) Table 62. North America Japanese Encephalitis Inactivated Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 64. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 65. North America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 66. North America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 67. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 69. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 70. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 71. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 72. Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 74. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 75. Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 76. Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 77. South America Japanese Encephalitis Inactivated Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. South America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 79. South America Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 80. South America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 81. South America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 82. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 84. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 85. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 88. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 89. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2026) Table 90. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2027-2032) Table 91. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 92. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 93. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2026) Table 94. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2027-2032) Table 95. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2026) & (US$/Unit) Table 96. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2027-2032) & (US$/Unit) Table 97. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 98. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 99. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2026) Table 100. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2027-2032) Table 101. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 102. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 103. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2026) Table 104. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2027-2032) Table 105. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2026) & (US$/Unit) Table 106. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2027-2032) & (US$/Unit) Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Japanese Encephalitis Inactivated Vaccine Distributors List Table 110. Japanese Encephalitis Inactivated Vaccine Customers List Table 111. Japanese Encephalitis Inactivated Vaccine Industry Trends Table 112. Japanese Encephalitis Inactivated Vaccine Industry Drivers Table 113. Japanese Encephalitis Inactivated Vaccine Industry Restraints Table 114. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Japanese Encephalitis Inactivated Vaccine Product Image Figure 5. Global Japanese Encephalitis Inactivated Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Japanese Encephalitis Inactivated Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Japanese Encephalitis Inactivated Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Japanese Encephalitis Inactivated Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Adult Product Image Figure 10. Child Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Japanese Encephalitis Inactivated Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Japanese Encephalitis Inactivated Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Japanese Encephalitis Inactivated Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Japanese Encephalitis Inactivated Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Japanese Encephalitis Inactivated Vaccine Sales by Region in 2025 Figure 19. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region in 2025 Figure 20. North America Japanese Encephalitis Inactivated Vaccine Market Size by Country in 2025 Figure 21. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country in 2025 Figure 26. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 27. Europe Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2021-2032) Figure 28. Germany Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Japanese Encephalitis Inactivated Vaccine Market Size by Country in 2025 Figure 34. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2021-2032) Figure 36. China Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Japanese Encephalitis Inactivated Vaccine Market Size by Country in 2025 Figure 45. South America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 46. South America Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2021-2032) Figure 47. Mexico Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size by Country in 2025 Figure 51. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 52. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Turkey Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Saudi Arabia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. UAE Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2032) Figure 57. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2032) Figure 58. Global Japanese Encephalitis Inactivated Vaccine Price (US$/Unit) by Type (2021-2032) Figure 59. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2032) Figure 60. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2032) Figure 61. Global Japanese Encephalitis Inactivated Vaccine Price (US$/Unit) by Application (2021-2032) Figure 62. Japanese Encephalitis Inactivated Vaccine Value Chain Figure 63. Japanese Encephalitis Inactivated Vaccine Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Adult
  • Child
Applications
  • Hospital
  • Clinic
Companies covered
  • Liaoning Chengda Biological Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Valneva
  • Sanofi Pasteur
  • Biken

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Japanese Encephalitis Inactivated Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales (2021-2032)
  5. 2.2.3 Global Japanese Encephalitis Inactivated Vaccine Market Average Price (2021-2032)
  6. 2.3 Japanese Encephalitis Inactivated Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Adult
  9. 2.3.3 Child
  10. 2.4 Japanese Encephalitis Inactivated Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Japanese Encephalitis Inactivated Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Japanese Encephalitis Inactivated Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Japanese Encephalitis Inactivated Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Japanese Encephalitis Inactivated Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Japanese Encephalitis Inactivated Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Japanese Encephalitis Inactivated Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Japanese Encephalitis Inactivated Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Japanese Encephalitis Inactivated Vaccine, Established Date
  9. 3.9 Global Japanese Encephalitis Inactivated Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Liaoning Chengda Biological Co., Ltd
  2. 4.1.1 Liaoning Chengda Biological Co., Ltd Company Information
  3. 4.1.2 Liaoning Chengda Biological Co., Ltd Business Overview
  4. 4.1.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  6. 4.1.5 Liaoning Chengda Biological Co., Ltd Recent Developments
  7. 4.2 Lanzhou Institute of Biological Products Co., Ltd
  8. 4.2.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  9. 4.2.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  10. 4.2.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  12. 4.2.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  13. 4.3 Chengdu Institute of Biological Products Co., Ltd
  14. 4.3.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  15. 4.3.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  16. 4.3.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  18. 4.3.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  19. 4.4 Beijing Institute of Biological Products Co., Ltd
  20. 4.4.1 Beijing Institute of Biological Products Co., Ltd Company Information
  21. 4.4.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  22. 4.4.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  24. 4.4.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
  25. 4.5 Valneva
  26. 4.5.1 Valneva Company Information
  27. 4.5.2 Valneva Business Overview
  28. 4.5.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio
  30. 4.5.5 Valneva Recent Developments
  31. 4.6 Sanofi Pasteur
  32. 4.6.1 Sanofi Pasteur Company Information
  33. 4.6.2 Sanofi Pasteur Business Overview
  34. 4.6.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio
  36. 4.6.5 Sanofi Pasteur Recent Developments
  37. 4.7 Biken
  38. 4.7.1 Biken Company Information
  39. 4.7.2 Biken Business Overview
  40. 4.7.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio
  42. 4.7.5 Biken Recent Developments
5 Global Japanese Encephalitis Inactivated Vaccine Market Scenario by Region
  1. 5.1 Global Japanese Encephalitis Inactivated Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Japanese Encephalitis Inactivated Vaccine Value Chain Analysis
  2. 8.1.1 Japanese Encephalitis Inactivated Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Japanese Encephalitis Inactivated Vaccine Production Mode & Process
  5. 8.2 Japanese Encephalitis Inactivated Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Japanese Encephalitis Inactivated Vaccine Distributors
  8. 8.2.3 Japanese Encephalitis Inactivated Vaccine Customers
9 Global Japanese Encephalitis Inactivated Vaccine Analyzing Market Dynamics
  1. 9.1 Japanese Encephalitis Inactivated Vaccine Industry Trends
  2. 9.2 Japanese Encephalitis Inactivated Vaccine Industry Drivers
  3. 9.3 Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges
  4. 9.4 Japanese Encephalitis Inactivated Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst